Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02071485 · ClinicalTrials.gov registry record
Non-Invasive Brain-Computer Interface for Virtual Object Control
A clinical trial of Individuality, sponsored by University of Minnesota.
- Completed
- Registry status
- 205
- Enrollment target
- 1
- Study location
NCT02071485: Completed study of Individuality, sponsored by University of Minnesota.
NCT02071485 is a study of Individuality that has completed, run by University of Minnesota. The registered enrollment target is 205 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02071485, a study of Individuality, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 205 participants
- Enrollment target
- 1
- Study location
Study Summary
A brain-computer interface (BCI) is a system that provides a separate output pathway for neurological signals whereby they can be interpreted to determine the user's intended cognitive action. Utilizing EEG-based sensorimotor rhythms (SMRs) generated in the motor cortex has allowed subjects to control virtual computer cursors in up to three dimensions by simply imagining the movement of a specified body part. Nevertheless, the scalp EEG signals are smeared by the volume conduction effect and measurement noise. The overall hypothesis of this study is that EEG-based virtual object control may help reveal optimal motor imagination tasks best used in a BCI. The PI's hypotheses include: (1) The use of advanced signal processing techniques will better reveal characteristics of EEG signals that represent the underlying motor cognitive function of the subject; (2) BCI systems based on SMR generated using motor imaginations will allow effective control of a virtual object in real time; (3) EEG imaging techniques will provide insight into the areas of cortical activation during a motor imagery task that can be utilized to increase the spatial resolution of non-invasive BCI's.
Conditions Studied
Study Locations (1)
Minnesota
- Nils Hasselmo Hall at the University of Minnesota - Twin Cities campus - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2014-03 |
| Est. Completion | 2018-01-08 |
What the finished NCT02071485 record still lists
NCT02071485 is an observational study that tracks outcomes without assigning an intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Individuality appearing as the primary indexed condition, and to 0 interventions.
NCT02071485 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02071485 about?
NCT02071485 is a clinical study titled "Non-Invasive Brain-Computer Interface for Virtual Object Control". A brain-computer interface (BCI) is a system that provides a separate output pathway for neurological signals whereby they can be interpreted to determine the user's intended cognitive action. Utilizing EEG-based sensorimotor rhythms (SMRs) generated in the motor cortex has allowed subjects to contr...
What is the current status of trial NCT02071485?
This trial is currently completed. The enrollment target is 205 participants. The study started on 2014-03. Estimated completion is 2018-01-08.
What conditions does trial NCT02071485 study?
This clinical trial studies the following conditions: Individuality.
Who is sponsoring clinical trial NCT02071485?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02071485 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia